Form 8-K - Current report:
SEC Accession No. 0000950170-24-038690
Filing Date
2024-03-29
Accepted
2024-03-29 16:30:12
Documents
11
Period of Report
2024-03-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K atra-20240326.htm   iXBRL 8-K 35108
  Complete submission text file 0000950170-24-038690.txt   147547

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atra-20240326.xsd EX-101.SCH 24861
14 EXTRACTED XBRL INSTANCE DOCUMENT atra-20240326_htm.xml XML 4728
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36548 | Film No.: 24804420
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)